We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Selective estrogen-receptor modulators and aromatase inhibitors: promising new medical therapies for endometriosis?
- Authors
Simsa, Peter; Mihalyi, Attila; Kyama, Cleophas M.; Mwenda, Jason M.; Fülöp3 &, Vilmos; D'Hooghe, Thomas M.
- Abstract
Endometriosis is an estrogen-dependent disease and estrogen-related pathways are imbalanced in women with endometriosis. One of the key enzymes in estrogen synthesis is aromatase. Inhibiting this pathway at several points is a promising idea for the treatment of endometriosis. The third generation of aromatase inhibitors is becoming more potent in efficacy, with fewer side effects than previous generations, but cotreatment with other hormones is needed to inhibit ovarian stimulation. Other components that promote estrogen synthesis such as COX-2 can also be potentially targeted. Selective estrogen-receptor modulators could also be interesting in view of their tissue-specific effect However, all these new drugs are still in an early phase of development. At present, it is too early to conclude that aromatase inhibitors, COX-2 inhibitors or selective estrogen-receptor modulators really present any added value compared with the existing drugs that can be used to achieve hormonal suppression in the medical treatment of endometriosis.
- Subjects
ESTROGEN; SEX hormones; STEROID hormones; IMMUNOMODULATORS; DRUG side effects; ENDOMETRIOSIS
- Publication
Women's Health (17455057), 2007, Vol 3, Issue 5, p617
- ISSN
1745-5057
- Publication type
Article
- DOI
10.2217/17455057.3.5.617